3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
3
Ovarian Neoplasms
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Osteosarcoma
1
Fanconi Anemia, Complementation Group D1
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
Doxorubicin
3
spartalizumab
1
nilotinib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
envafolimab
1
Trabectedin
1
TQ-B3525
1
Radiotherapy
1
Proton Therapy
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Ifosfamide
1
Heavy Ion Radiotherapy
1
Gelclair
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Chondrosarcoma
×
Trabectedin
×
Clear all
NCT05131386
2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
85 enrolled